Janssen

Results: 1194



#Item
981HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RISPERDAL® safely and effectively. See full prescribing information for RISPERDAL®. RISPERDAL® (risperidone) tabl

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RISPERDAL® safely and effectively. See full prescribing information for RISPERDAL®. RISPERDAL® (risperidone) tabl

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-29 16:03:06
982IMPORTANT DRUG WARNING October 19, 2004 IMPORTANT SAFETY ALERT REGARDING MEDICATION ERRORS Dear Pharmacist: Janssen Pharmaceutica Products, L.P. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. have re

IMPORTANT DRUG WARNING October 19, 2004 IMPORTANT SAFETY ALERT REGARDING MEDICATION ERRORS Dear Pharmacist: Janssen Pharmaceutica Products, L.P. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. have re

Add to Reading List

Source URL: www.fda.gov

Language: English
983HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing information for CAPRELSA. CAPRELSA® (vandetanib) Tablets for

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing information for CAPRELSA. CAPRELSA® (vandetanib) Tablets for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-01 13:41:25
984CHF Labeling – [removed]clean) 1 JANSSEN PHARMACEUTICA

CHF Labeling – [removed]clean) 1 JANSSEN PHARMACEUTICA

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 17:01:36
9858401 W. DODGE RD., SUITE #115, OMAHA, NE 68114; [removed]; ([removed]/03 FROM: Steven A. Seifert, MD, Medical Director

8401 W. DODGE RD., SUITE #115, OMAHA, NE 68114; [removed]; ([removed]/03 FROM: Steven A. Seifert, MD, Medical Director

Add to Reading List

Source URL: www.nebraskapoison.com

Language: English - Date: 2009-12-03 12:38:36
9868401 W. Dodge Rd. Suite #115, Omaha, NE 68114; [removed]; ([removed]04 FROM: Steven A. Seifert, MD, Medical Director

8401 W. Dodge Rd. Suite #115, Omaha, NE 68114; [removed]; ([removed]04 FROM: Steven A. Seifert, MD, Medical Director

Add to Reading List

Source URL: www.nebraskapoison.com

Language: English - Date: 2009-12-03 12:38:36
987NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement (BNE) Bureau of Emergency Medical Services (EMS) Fentanyl Quarterly Report For

NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement (BNE) Bureau of Emergency Medical Services (EMS) Fentanyl Quarterly Report For

Add to Reading List

Source URL: www.health.ny.gov

Language: English - Date: 2013-04-10 12:46:46
988Global HIV Access & Partnerships Program GAPP Status: Optimizing Use of Our HIV Medicines in Resource-Limited Countries AT JANSSEN, we are committed to helping people living with HIV in resource-limited settings by ensur

Global HIV Access & Partnerships Program GAPP Status: Optimizing Use of Our HIV Medicines in Resource-Limited Countries AT JANSSEN, we are committed to helping people living with HIV in resource-limited settings by ensur

Add to Reading List

Source URL: www.janssenrnd.com

Language: English - Date: 2012-07-18 12:14:17
989August 8, 2013 Press release: Mitsubishi Tanabe Pharma Corporation Notice Regarding Arbitration Award in Dispute with Janssen Biotech, Inc. Osaka, Japan, August 8, [removed]Mitsubishi Tanabe Pharma Corporation (Head Office

August 8, 2013 Press release: Mitsubishi Tanabe Pharma Corporation Notice Regarding Arbitration Award in Dispute with Janssen Biotech, Inc. Osaka, Japan, August 8, [removed]Mitsubishi Tanabe Pharma Corporation (Head Office

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-08-07 23:15:44
990Collaborative Research Agreement Between Janssen Pharmaceutical Research & Development

Collaborative Research Agreement Between Janssen Pharmaceutical Research & Development

Add to Reading List

Source URL: www.ncats.nih.gov

Language: English - Date: 2014-05-12 12:58:35